Required fields are marked with *

Verification code

SARS-CoV

CAS No. Product Name Inquiry
443776-49-6
BC-11 hydrobromide
BC 11 hydrobromide is a selective urokinase (uPA) inhibitor (IC50 = 8.2 μM) with no activity at 8 other related enzymes. BC 11 inhibits clot lysis displaying no effect on clot formation. It also decreases viability of MDA-MB231 breast cancer cells in vitro.
4774-24-7
Quipazine
501000-36-8
Dutacatib
50597-93-8
Isojacareubin
Isojacareubin is a natural xanthone compound found in several plants.
50906-56-4
Arteannuin B
Arteannuin B is a natural sesquiterpenoid found in the herbs of Artemisia annua, it exhibits potent antimalarial activity and has potential antitumor activity.
50924-49-7
Mizoribine
Bredinin is a nucleoside antibiotic produced by Eupenicillum brefeldianum M-2166. It has anti-L-5178Y cell and anti-pox virus activity, not against bacteria and fungi,
51773-92-3
Mefloquine Hydrochloride
Mefloquine HCl is a blood schizonticide by inhibiting hemozoin formation, used as an antimalarial drug.
522660-61-3
SARS-CoV-2-nsp13-IN-2
SARS-CoV-2 nsp13-IN-2 (Compound C2) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 42 μM against nsp13 ssDNA+ ATPase.
52869-18-8
SSAA09E3
SSAA09E3 is a novel inhibitor of SARS-CoV and HIV-1. SSAA09E3 blocks SARS-CoV entry by preventing fusion of the viral membrane with the host cellular membrane.
529-53-3
Scutellarein
Scutellarin and Scutellarein could improve neuronal injury, and Scutellarein had better protective effect than scutellarin in rat cerebral ischemia.
531-58-8
Cichoriin
Aesculetin-7-O-D-Glucopyranoside is isolated from chicory.
53230-10-7
Mefloquine
Mefloquine is, a quinoline methanol phospholipid-interacting antimalarial drug, is very effective against sensitive malaria parasites with few side effects. Mefloquine may cause vomiting, especially in children.
54-05-7
Chloroquine
An antimalarial agent.
56961-10-5
SARS-CoV-2-IN-13
SARS-CoV-2-IN-13 (compound 5) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.057 μM. SARS-CoV-2-IN-13 is a niclosamide analogue. SARS-CoV-2-IN-13 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally. SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication, is an attractive target for intervention. SARS-CoV-2-IN-11 may lead to the emergence of effective SARS-CoV-2-specific antivirals.
57132-53-3
Proglumetacin
57341-12-5
SARS-CoV-2-IN-80
57685-46-8
Kansuinine B
Kansuinine B from Euphorbia kansui L, inhibits IL-6-induced Stat3 activation. It could be used in the study for COVID-19.
582-24-1
2-Hydroxyacetophenone
2-Hydroxyacetophenone (CAS# 582-24-1) is a useful reactant for synthesis of diarylpyrazoles as cyclooxygenase 2 inhibitors.
58581-89-8
Azelastine
Azelastine, a phthalazine derivative, is a potent, second-generation, selective, histamine antagonist used as a first line therapy of mild intermittent.
58976-18-4
SARS-CoV-2-IN-76

※ Please kindly note that our services are for research use only.

Copyright © 2024 BOC Sciences. All rights reserved.